{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:19:33Z","timestamp":1789985973917,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":976,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000243","name":"Weston Brain Institute Rapid Response Grant","doi-asserted-by":"publisher","award":["RR150031"],"award-info":[{"award-number":["RR150031"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1194\/jlr.m081851","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T18:15:42Z","timestamp":1521656142000},"page":"830-842","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":48,"title":["Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway"],"prefix":"10.1016","volume":"59","author":[{"given":"Jianjia","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Parro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Ya","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Z.","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Raynoschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Barichievy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Engkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Meuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Kulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M081851_bib1","doi-asserted-by":"crossref","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1194\/jlr.M081851_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/alzrt204","article-title":"Apolipoprotein E as a beta-amyloid-independent factor in Alzheimer's disease","volume":"5","author":"Wolf","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1194\/jlr.M081851_bib3","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M081851_bib4","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice","volume":"285","author":"Donkin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M081851_bib5","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","article-title":"The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease","volume":"280","author":"Hirsch-Reinshagen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M081851_bib6","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M081851_bib7","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M081851_bib8","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M081851_bib9","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/humu.21076","article-title":"A survey of ABCA1 sequence variation confirms association with dementia","volume":"30","author":"Reynolds","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1194\/jlr.M081851_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","article-title":"Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease","volume":"11","author":"Nordestgaard","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1194\/jlr.M081851_bib11","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1523\/JNEUROSCI.2053-15.2015","article-title":"microRNA-33 regulates ApoE lipidation and amyloid-beta metabolism in the brain","volume":"35","author":"Kim","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1194\/jlr.M081851_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron."},{"key":"10.1194\/jlr.M081851_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt187","article-title":"Evidence for impaired amyloid beta clearance in Alzheimer's disease","volume":"5","author":"Wildsmith","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1194\/jlr.M081851_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbalip.2011.04.003","article-title":"Modulation of RXR function through ligand design","volume":"1821","author":"P\u00e9rez","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.M081851_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1194\/jlr.M081851_bib16","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1194\/jlr.M300135-JLR200","article-title":"The LXR ligand T0901317 induces severe lipogenesis in the db\/db diabetic mouse","volume":"44","author":"Chisholm","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M081851_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1208\/s12248-012-9429-3","article-title":"The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance","volume":"15","author":"Gao","year":"2013","journal-title":"AAPS J."},{"key":"10.1194\/jlr.M081851_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1096\/fj.09-138883","article-title":"The P2X7 purinergic receptor: from physiology to neurological disorders","volume":"24","author":"Skaper","year":"2010","journal-title":"FASEB J."},{"key":"10.1194\/jlr.M081851_bib19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/me.2008-0453","article-title":"Negative regulation of Hedgehog signaling by liver X receptors","volume":"23","author":"Kim","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1194\/jlr.M081851_bib20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1194\/jlr.M014365","article-title":"An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia","volume":"52","author":"Fan","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M081851_bib21","doi-asserted-by":"crossref","first-page":"16153","DOI":"10.1073\/pnas.0607973103","article-title":"Isoelectric focusing technology quantifies protein signaling in 25 cells","volume":"103","author":"O'Neill","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M081851_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.f.353","article-title":"The Simple Western\u2122: a gel-free, blot-free, hands-free Western blotting reinvention","volume":"8","author":"Nguyen","year":"2011","journal-title":"Nat. Methods."},{"key":"10.1194\/jlr.M081851_bib23","doi-asserted-by":"crossref","first-page":"e0162384","DOI":"10.1371\/journal.pone.0162384","article-title":"Identification of a chrysanthemic ester as an apolipoprotein E inducer in astrocytes","volume":"11","author":"Fan","year":"2016","journal-title":"PLoS One."},{"key":"10.1194\/jlr.M081851_bib24","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bmcl.2009.02.039","article-title":"Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides","volume":"19","author":"Swahn","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1194\/jlr.M081851_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/138620711795222446","article-title":"Two panels of steroid receptor luciferase reporter cell lines for compound profiling","volume":"14","author":"Sedl\u00e1k","year":"2011","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1194\/jlr.M081851_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707372","article-title":"Good statistical practice in pharmacology. Problem 2","volume":"152","author":"Lew","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1194\/jlr.M081851_bib27","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/jm901797p","article-title":"Discovery of tertiary sulfonamides as potent liver X receptor antagonists","volume":"53","author":"Zuercher","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.M081851_bib28","article-title":"inventors; AstraZeneca UK Limited, assignee","author":"Zuercher","year":"2001","journal-title":"Novel compounds. United States patent US 20,010,003,121"},{"key":"10.1194\/jlr.M081851_bib29","article-title":"inventors; AstraZeneca AB, assignee","author":"Zuercher","year":"2002","journal-title":"United States patent US 6,492,355"},{"key":"10.1194\/jlr.M081851_bib30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1194\/jlr.M081851_bib31","first-page":"2247","article-title":"Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn's disease: a randomized placebo-controlled, double-blind, phase IIa study","volume":"21","author":"Eser","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1194\/jlr.M081851_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2014.05.007","article-title":"ATP-binding cassette transporter A1: from metabolism to neurodegeneration","volume":"72","author":"Koldamova","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1194\/jlr.M081851_bib33","doi-asserted-by":"crossref","first-page":"e002886","DOI":"10.1161\/JAHA.115.002886","article-title":"ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease","volume":"5","author":"Yassine","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1194\/jlr.M081851_bib34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1194\/jlr.M081851_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41598-017-00732-5","article-title":"Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120","volume":"7","author":"Allsopp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1194\/jlr.M081851_bib36","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/jm801528x","article-title":"Antagonists of the P2X(7) receptor. From lead identification to drug development","volume":"52","author":"Guile","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.M081851_bib37","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1021\/jm700949w","article-title":"Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists\/interleukin-1beta inhibitors","volume":"50","author":"Furber","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1194\/jlr.M081851_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropharm.2017.10.027","article-title":"P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease","volume":"128","author":"S\u00e1ez-Orellana","year":"2018","journal-title":"Neuropharmacology."},{"key":"10.1194\/jlr.M081851_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X(7) receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1194\/jlr.M081851_bib40","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol. Aging."},{"key":"10.1194\/jlr.M081851_bib41","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/WNR.0b013e3283179333","article-title":"Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease","volume":"19","author":"Ryu","year":"2008","journal-title":"Neuroreport."},{"key":"10.1194\/jlr.M081851_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","article-title":"Molecular and functional properties of P2X receptors\u2013recent progress and persisting challenges","volume":"8","author":"Kaczmarek-H\u00e1jek","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1194\/jlr.M081851_bib43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1194\/jlr.M081851_bib44","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","article-title":"Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373","volume":"149","author":"Stokes","year":"2006","journal-title":"Br. J. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.jlr.2022.100214","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000}}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520331187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520331187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M081851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T17:11:25Z","timestamp":1637428285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520331187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["S0022227520331187"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m081851","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jlr.2022.100214","asserted-by":"object"}]},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}